object
investig
blood
coagul
function
patient
correl
coagulopathi
diseas
sever
peopl
go
battl
novel
coronaviru
pneumonia
world
april
peopl
infect
die
worldwid
novel
coronaviru
confirm
pathogen
belong
beta
coronaviru
phylogenet
analysi
similar
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
respiratori
symptom
fever
dri
cough
pant
even
acut
respiratori
distress
syndrom
ard
acut
cardiac
injuri
manifest
patient
caus
seri
disord
coagul
system
includ
endotheli
damag
coagul
activ
intravascular
fibrin
deposit
patient
sever
coagul
activ
lead
format
thrombu
even
dissemin
intravascular
coagul
dic
coagul
activ
common
patient
preexist
coagul
disord
side
although
sever
patient
treat
extracorpor
membran
oxygen
ecmo
temporarili
replac
cardiopulmonari
function
coagul
disord
still
one
common
complic
ecmo
also
common
caus
disrupt
ecmo
therefor
signific
monitor
coagul
system
paramet
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
patient
determin
coagul
function
previou
studi
suggest
cytokin
storm
typic
abnorm
caus
underli
reason
connect
coagul
function
diseas
sever
complet
clear
especi
index
relat
thrombu
thrombinantithrombin
complex
tat
complex
pic
thrombomodulin
tm
complex
tpaic
import
marker
process
venou
thrombosi
significantli
increas
thrombosi
report
therefor
studi
execut
evalu
valu
coagul
function
predict
sever
patient
recruit
covid
patient
health
control
wuhan
leishenshan
hospit
hubei
china
patient
diagnos
classifi
follow
new
coronaviru
pneumonia
prevent
control
program
edit
publish
nation
health
commiss
china
briefli
control
hospit
employe
underw
healthi
examin
studi
approv
ethic
committe
zhongnan
hospit
wuhan
univers
sever
patient
follow
condit
respiratori
distress
rr
timesminut
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
statist
analysi
perform
spss
version
softwar
graphpad
prism
version
measur
data
test
normal
nonnorm
distribut
data
express
median
interquartil
rang
nonparametr
mannwhitney
test
use
comparison
two
group
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
univari
multivari
analysi
use
logist
regress
analysi
calcul
odd
ratio
confid
interv
predict
variou
indic
prognosi
patient
analyz
receiv
oper
characterist
roc
curv
area
roc
curv
auc
measur
evalu
predict
abil
statist
analysi
p
consid
statist
signific
among
patient
male
femal
median
age
year
control
group
subject
male
subject
femal
tabl
age
significantli
differ
among
group
mild
patient
sever
patient
critic
patient
patient
thrombot
diseas
patient
without
thrombot
diseas
level
coagul
paramet
health
control
patient
demonstr
tabl
patient
significantli
higher
valu
tat
pic
tm
tpaic
pt
inr
fib
dd
health
control
signific
differ
aptt
tt
plt
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
among
patient
patient
thrombot
diseas
without
thrombot
diseas
patient
die
among
thrombot
diseas
group
patient
die
nonthrombot
diseas
group
tabl
patient
thrombot
diseas
group
higher
casefat
rate
nonthrombot
diseas
group
p
level
coagul
paramet
thrombot
diseas
group
nonthrombot
diseas
group
demonstr
signific
differ
level
aptt
tt
plt
among
includ
patient
patient
belong
mild
group
sever
critic
tm
tpaic
pt
inr
dd
significantli
differ
among
three
group
tt
signific
differ
fig
j
sever
patient
higher
level
tm
tpaic
pt
inr
dd
tat
plt
significantli
differ
sever
critic
group
mild
critic
group
signific
found
mild
sever
group
fig
k
regard
pic
aptt
signific
differ
mild
sever
mild
critic
patient
signific
differ
sever
critic
group
fig
g
addit
signific
differ
level
fib
sever
group
mild
group
howev
signific
differ
found
sever
critic
group
mild
critic
patient
fig
roc
curv
auc
fig
demonstr
tm
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
analysi
use
univari
multivari
logist
regress
also
found
tpaic
dd
independ
risk
factor
patient
death
tabl
sensit
specif
tpaic
predict
death
respect
cutoff
greater
ngml
dd
cutoff
greater
mgl
report
coagul
function
patient
wuhan
leishenshan
hospit
hubei
china
world
health
organ
declar
intern
public
health
emerg
end
januari
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
within
period
four
month
peopl
infect
peopl
die
worldwid
although
patient
mild
symptom
good
prognosi
crude
mortal
rate
patient
progress
sever
critic
mortal
rate
increas
significantli
crude
death
rate
reach
critic
earli
identif
sever
patient
help
improv
recoveri
rate
reduc
mortal
studi
shown
patient
develop
varieti
secondari
diseas
caus
patholog
chang
hematolog
immun
biochemistri
etc
chang
coagulopathi
well
understood
studi
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
tpaic
predict
possibl
thrombosi
patient
earli
stage
tat
marker
activ
coagul
system
determin
optim
period
anticoagul
therapi
earli
diagnosi
thrombosi
predic
pic
marker
fibrinolyt
system
activ
predict
format
thrombu
assist
diagnosi
dic
guid
antifibrinolyt
treatment
elev
level
tm
indic
impair
vascular
endotheli
system
tpaic
key
marker
fibrinolyt
system
suggest
thrombu
progress
plasma
level
sensit
biomark
endotheli
injuri
patient
may
use
evalu
endotheli
injuri
besid
also
found
patient
thrombot
diseas
higher
casefat
rate
therefor
situat
requir
vigil
coagul
system
paramet
abnorm
patient
like
accompani
thrombosi
risk
death
greater
tat
pic
tm
tpaic
pt
inr
aptt
fib
dd
plt
also
found
correl
diseas
sever
tt
correl
fig
tt
time
plasma
coagul
ad
prothrombin
solut
plasma
reflect
presenc
anticoagul
base
clinic
practic
roc
analysi
mild
nonmild
patient
fig
cutoff
valu
test
item
obtain
tm
tuml
tpaic
ngml
pt
dd
mgl
progress
sever
ill
close
observ
prevent
among
rise
dd
concentr
obviou
similar
wang
guan
studi
dd
elev
inflamm
caus
coagul
activ
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
result
suggest
valu
coagul
system
paramet
patient
attent
avoid
progress
report
anticoagul
treatment
requir
sever
critic
patient
dd
use
indic
adjust
anticoagul
therapi
improv
prognosi
revers
intravascular
coagul
microthrombi
format
fibrin
deposit
patient
might
need
anticoagul
fibrinolyt
therapi
found
patient
death
group
significantli
higher
level
tat
tm
tpaic
pt
inr
aptt
dd
surviv
group
plt
decreas
shown
patient
thrombocytopenia
elev
level
dd
prolong
aptt
suggest
patient
death
may
associ
dic
sever
patient
develop
dyspnea
hypoxemia
one
week
onset
lung
seriou
ga
exchang
perform
ventil
restor
lung
function
ecmo
becom
effect
treatment
rescu
critic
patient
temporarili
replac
cardiopulmonari
function
still
mani
complic
among
coagul
system
disord
still
one
common
complic
ecmo
termin
ecmo
therefor
safe
scientif
monitor
ecmo
loop
thrombosi
patient
earli
intervent
reduc
harm
complic
promot
effect
circul
support
ecmo
tat
pic
tm
tpaic
indic
earli
predict
monitor
dic
dd
indic
thrombu
occur
ongo
find
demonstr
predict
tpaic
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
correspond
request
materi
address
wen
xie
author
contribut
equal
wen
xie
idea
design
studi
wen
xie
xin
jin
yongwei
duan
full
access
data
studi
take
respons
integr
data
accuraci
data
analysiswen
xie
contribut
critic
revis
report
xin
jin
contribut
statist
analysi
author
contribut
data
acquisit
data
analysi
data
interpret
review
approv
final
version
xin
jin
yongwei
duan
contribut
equal
share
first
authorship
xin
jin
yongwei
duan
contribut
equal
articl
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
